Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Zepbound, the brand-name tirzepatide injection, typically ships with four pre-filled pens per box—one pen per week for a complete month of therapy. Each pen delivers a single subcutaneous injection that activates dual GLP-1 and GIP receptors, driving appetite suppression and metabolic changes. PlexusDx offers compounded tirzepatide injection as a medically equivalent alternative starting at $249 per month, with identical weekly dosing flexibility across all commitment tiers.
How Many Pens Come in a Zepbound Box?
Zepbound boxes contain four pre-filled, single-use pens arranged in individual cartons. Each pen represents one week of therapy in the standard titration protocol, meaning one box covers one complete month of treatment. The pens are color-coded by dose strength—2.5 mg (yellow), 5 mg (purple), 7.5 mg (teal), and 10 mg (green)—making it easy to identify your prescribed dose at a glance.
The four-pen monthly supply reflects the FDA-approved titration schedule, where patients typically start at 2.5 mg and increase by 2.5 mg increments every four weeks. Once patients reach their maintenance dose, they continue weekly injections indefinitely. Storage requirements mandate refrigeration between 36°F and 46°F, though individual pens can remain at room temperature for up to 30 days after removal from the refrigerator.
Tirzepatide Dosing Schedule and Titration Steps
Tirzepatide dosing follows a progressive escalation model designed to minimize gastrointestinal side effects while maximizing weight loss outcomes. The standard protocol begins at 2.5 mg weekly for four weeks, then advances to 5 mg, 7.5 mg, and finally 10 mg if tolerated. However, not all patients proceed through every dose tier—some reach their optimal response at intermediate levels and maintain that dose long-term.
The dosing flexibility allows clinical teams to adjust based on individual tolerability and metabolic response. Clinical trials demonstrate that doses of 10 mg produce average weight loss of 20-22% body weight over 68 weeks, while lower maintenance doses (5-7.5 mg) still deliver 15-18% reductions. PlexusDx compounded tirzepatide injection maintains identical dose options and titration protocols, allowing seamless transitions between brand-name and compounded therapies without clinical interruption.
Compounded vs. Brand-Name Tirzepatide: What's the Difference?
Brand-name Zepbound and PlexusDx compounded tirzepatide injections contain the same active pharmaceutical ingredient formulated by licensed 503A compounding pharmacies. The primary differences lie in packaging, supply chain, and cost structure. Brand-name products arrive in standardized boxes with specific pen counts and marketing-driven presentation, while compounded products provide equivalent pharmacological action at lower monthly costs without dose-dependent pricing tiers.
PlexusDx tirzepatide injection starts at $249 per month flat—meaning your dose may increase as you titrate upward, but your monthly price remains consistent. This eliminates hidden cost escalations that occur with some direct-to-consumer programs. Both formulations undergo identical quality controls and require prescriptions from licensed healthcare providers, ensuring medical oversight and safety monitoring throughout treatment.
Why Pen Count Matters for Treatment Planning
Understanding pen quantities helps patients plan refill schedules, storage logistics, and medication adherence strategies. A four-pen monthly supply requires consistent refrigeration space and monthly coordination with your pharmacy or telehealth provider. Patients who travel frequently or lack reliable refrigeration may need to adjust their delivery timing or discuss alternative formulations with their care team.
PlexusDx offers both injection and oral tirzepatide options, allowing flexible selection based on lifestyle and preference. Oral tirzepatide, available at $279 per month, eliminates injection-related logistics while maintaining identical dosing protocols and weight loss efficacy. For patients prioritizing maximum convenience or those with injection anxiety, oral formulations deliver comparable results without weekly pen management concerns.
Maximizing Your Tirzepatide Treatment with Genetic Insights
Individual response to tirzepatide varies significantly based on genetic predispositions affecting peptide signaling pathways. PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) identifies key variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation, satiety signaling, and metabolic efficiency. These insights enable personalized dose optimization and combination therapy recommendations tailored to your specific genetic profile.
The genetic testing maps 14 distinct pathways across 49 peptide biomarkers, revealing 150+ actionable insights that guide dose selection and protocol adjustments. Patients carrying certain FTO rs9939609 variants may respond better to higher tirzepatide doses, while those with specific GLP1R rs6923761 signatures might achieve optimal results at intermediate maintenance levels. This precision approach transforms one-size-fits-all dosing into individually calibrated therapy that maximizes weight loss while minimizing unnecessary escalation and side effects.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do all Zepbound boxes contain exactly four pens?
Yes, standard Zepbound packaging includes four pre-filled pens representing the complete weekly titration sequence for one month. Each pen delivers one dose, and the four-week supply aligns with the FDA-approved dose escalation protocol moving from 2.5 mg through 10 mg maintenance strength.
What clinical evidence supports tirzepatide's effectiveness for weight loss?
The SURMOUNT clinical trials demonstrated that tirzepatide produces 20-22% average body weight reduction at 10 mg dose over 68 weeks, compared to 3% with placebo. PlexusDx compounded tirzepatide contains identical active ingredients, delivering equivalent efficacy outcomes supported by the same peer-reviewed evidence.
How much does compounded tirzepatide cost compared to brand-name Zepbound?
PlexusDx compounded tirzepatide injection starts at $249 per month flat across all commitment tiers, with no dose-dependent price increases as you titrate upward. This pricing structure offers significant savings compared to brand-name alternatives while maintaining identical pharmaceutical quality from licensed 503A compounding pharmacies.
Are there safety concerns with compounded tirzepatide?
PlexusDx sourcing from licensed 503A compounding pharmacies ensures rigorous quality standards, sterility testing, and pharmaceutical compliance. Compounded tirzepatide carries the same safety profile as brand-name formulations, with identical side effect patterns and adverse event monitoring protocols required by regulatory oversight.
How does genetic testing improve my tirzepatide dosing strategy?
PlexusDx Precision Peptide Genetic Test identifies GLP1R, GIPR, FTO, and MC4R variants that predict your individual response to tirzepatide dose escalation. This $99 test reveals which dose level optimizes your weight loss trajectory while minimizing side effects, enabling personalized medicine approach rather than standard protocol adjustments.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss with Wegovy and Synthroid: What You Need to Know
Postpartum Weight Loss: Is Ozempic Safe?